Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
Biotech firm Metsera, supported by Google Ventures, is aiming to raise $292 million through an initial public offering (IPO). Concurrently, the biotech accelerator and investment firm Curie Bio has successfully raised $340 million for a new seed fund to invest in startups. This brings Curie Bio's total under management to over $1 billion, with a team approaching 100 members. The firm was co-founded by Alexis Borisy and Zach Weinberg, who are focused on funding innovative biotech solutions. Additionally, Swiss biopharma company BioVersys has launched its IPO on the SIX Swiss Exchange, seeking to raise 80 million Swiss francs, with shares priced at 36 Swiss francs ($39.84) each.
Congrats to @mevvynetwork on the raise! Proud to be backing these guys. Co-founders @BobDeFarmer and @whammerguygaren are certified gigabrains and I look forward to seeing what they build! https://t.co/TOydTSTMI5
More $ for more new medicines. Now $1b+ under management and team nearing 100 people. https://t.co/biF5PydljW
Getting ready for IPO: @Bioversys announces the share price at CHF 36.00 ahead of listing at SIX Swiss Exchange. Kudos to the team of our alumni Marc Gitzinger and Sergio Lociuro, wishing you an amazing debut and countless new investors, backing the future of live-savingโฆ https://t.co/4I2JR1vOnN
